These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 24504827)

  • 1. Recent advances in the pharmacotherapy of infantile spasms.
    Riikonen R
    CNS Drugs; 2014 Apr; 28(4):279-90. PubMed ID: 24504827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
    Iyer A; Appleton R
    Paediatr Drugs; 2016 Oct; 18(5):357-66. PubMed ID: 27541933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms.
    Askalan R; Mackay M; Brian J; Otsubo H; McDermott C; Bryson S; Boyd J; Snead C; Roberts W; Weiss S
    J Child Neurol; 2003 Mar; 18(3):165-70. PubMed ID: 12731640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical treatment of patients with infantile spasms.
    Mikati MA; Lepejian GA; Holmes GL
    Clin Neuropharmacol; 2002; 25(2):61-70. PubMed ID: 11981230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology and the Child Neurology Society.
    Mackay MT; Weiss SK; Adams-Webber T; Ashwal S; Stephens D; Ballaban-Gill K; Baram TZ; Duchowny M; Hirtz D; Pellock JM; Shields WD; Shinnar S; Wyllie E; Snead OC; ;
    Neurology; 2004 May; 62(10):1668-81. PubMed ID: 15159460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A risk-benefit assessment of treatments for infantile spasms.
    Nabbout R
    Drug Saf; 2001; 24(11):813-28. PubMed ID: 11665869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to treatment in a prospective national infantile spasms cohort.
    Knupp KG; Coryell J; Nickels KC; Ryan N; Leister E; Loddenkemper T; Grinspan Z; Hartman AL; Kossoff EH; Gaillard WD; Mytinger JR; Joshi S; Shellhaas RA; Sullivan J; Dlugos D; Hamikawa L; Berg AT; Millichap J; Nordli DR; Wirrell E;
    Ann Neurol; 2016 Mar; 79(3):475-84. PubMed ID: 26704170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and treatment of infantile spasms using vigabatrin and ACTH--a developing country perspective.
    Ibrahim S; Gulab S; Ishaque S; Saleem T
    BMC Pediatr; 2010 Jan; 10():1. PubMed ID: 20078871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adrenocorticotropic hormone for the treatment of West Syndrome in children.
    Shumiloff NA; Lam WM; Manasco KB
    Ann Pharmacother; 2013 May; 47(5):744-54. PubMed ID: 23606552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newer GABAergic agents for pharmacotherapy of infantile spasms.
    Reddy DS
    Drugs Today (Barc); 2002 Oct; 38(10):657-75. PubMed ID: 12582452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A plausible explanation for superiority of adreno-cortico-trophic hormone (ACTH) over oral corticosteroids in management of infantile spasms (West syndrome).
    Jaseja H
    Med Hypotheses; 2006; 67(4):721-4. PubMed ID: 16781824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Infantile spasms: experience in 13 cases].
    Fonseca LF; Oliveira AL
    Arq Neuropsiquiatr; 2000 Jun; 58(2B):512-7. PubMed ID: 10920415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment modalities for infantile spasms: current considerations and evolving strategies in clinical practice.
    Hollenshead PP; Jackson CN; Cross JV; Witten TE; Anwar AI; Ahmadzadeh S; Shekoohi S; Kaye AD
    Neurol Sci; 2024 Feb; 45(2):507-514. PubMed ID: 37736852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favourable prognostic factors with infantile spasms.
    Riikonen RS
    Eur J Paediatr Neurol; 2010 Jan; 14(1):13-8. PubMed ID: 19362867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroids or vigabatrin in the treatment of infantile spasms?
    Riikonen RS
    Pediatr Neurol; 2000 Nov; 23(5):403-8. PubMed ID: 11118795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.
    Go CY; Mackay MT; Weiss SK; Stephens D; Adams-Webber T; Ashwal S; Snead OC; ;
    Neurology; 2012 Jun; 78(24):1974-80. PubMed ID: 22689735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile spasms: therapy and outcome.
    Riikonen R
    J Child Neurol; 2004 Jun; 19(6):401-4. PubMed ID: 15446386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infantile spasms.
    Wong M; Trevathan E
    Pediatr Neurol; 2001 Feb; 24(2):89-98. PubMed ID: 11275456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication selection, health services outcomes, and cost trajectories for Medicaid beneficiaries with infantile spasms.
    Min JY; Knupp KG; Patel AD; Shellhaas RA; Zhang M; Grinspan ZM
    Epilepsy Res; 2021 Oct; 176():106733. PubMed ID: 34333373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vigabatrin for infantile spasms.
    Pesaturo KA; Spooner LM; Belliveau P
    Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.